Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokines

Objective: To analyze literature data and compare the common pathways of inflammation in inflammatory bowel diseases (IBD) and atherosclerosis with focus on the effects of proinflammatory cytokines on both pathologies, as well as from the perspective of potential role of gene polymorphism of proinfl...

Full description

Saved in:
Bibliographic Details
Main Authors: Zinaida M. Zhigula, Albina A. Zhilina, Natalia V. Lareva
Format: Article
Language:Russian
Published: MONIKI 2024-12-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
Online Access:https://almclinmed.ru/jour/article/viewFile/17271/1709
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850060132452401152
author Zinaida M. Zhigula
Albina A. Zhilina
Natalia V. Lareva
author_facet Zinaida M. Zhigula
Albina A. Zhilina
Natalia V. Lareva
author_sort Zinaida M. Zhigula
collection DOAJ
description Objective: To analyze literature data and compare the common pathways of inflammation in inflammatory bowel diseases (IBD) and atherosclerosis with focus on the effects of proinflammatory cytokines on both pathologies, as well as from the perspective of potential role of gene polymorphism of proinflammatory cytokines in the pathophysiology of atherosclerosis in IBD patients. Main provisions: In IBD, a serum cytokine profile initiates and supports the chronic inflammation. The main immunological mechanisms in both IBD and atherosclerosis are mediated by hyperproduction of proinflammatory cytokines, such as tumor necrosis factor α (TNF-α), interleukins (IL) IL-1β, IL-6, IL-8, IL-12, IL-23, IL-17, and relative insufficiency of anti-inflammatory IL-4 and IL-10, with significant increase in pro-inflammatory cytokines. An association has been established between the polymorphisms of TNF-α (rs1800629), IL-8 (rs117518778, rs8057084), IL-10 (rs3024505, rs1800896), IL-12 (rs6887695, rs10045431), IL-23 (rs11209026A) candidate genes and the development of ulcerative colitis (UC). The polymorphisms of the TNF-α (rs1800629), IL-8 (rs117518778, rs8057084), IL-1β (rs16944), IL-17A (rs2275913), IL-4 (rs2243250), IL-23 (rs6682925T/C) genes are associated with a high risk of atherosclerosis. Protein tyrosine phosphatase, receptor type, C (PTPRC) was identified as the hub crosstalk gene for the comorbidity of UC and atherosclerosis. The effects of cytokine genes polymorphisms as key targets of the pathogenetically oriented IBD therapy on the development of atherosclerosis in these patients remain a poorly investigated question. Conclusion: IBD and atherosclerosis are mediated by the shared mechanisms of enhanced synthesis of proinflammatory cytokines, as well as polymorphisms of the candidate genes. Studies on the polymorphism of proinflammatory cytokines genes and small molecules in patients with UC, as well as the association of these polymorphisms with the development of atherosclerosis would open up new possibilities for prediction of cardiovascular diseases in these patients, development of preventive measures, and for repositioning of biological therapy for the prevention and treatment of atherosclerosis.
format Article
id doaj-art-0b45b04a004045aeb44188c586cd1bac
institution DOAJ
issn 2072-0505
2587-9294
language Russian
publishDate 2024-12-01
publisher MONIKI
record_format Article
series Alʹmanah Kliničeskoj Mediciny
spelling doaj-art-0b45b04a004045aeb44188c586cd1bac2025-08-20T02:50:41ZrusMONIKIAlʹmanah Kliničeskoj Mediciny2072-05052587-92942024-12-0152840541610.18786/2072-0505-2024-52-0401016Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokinesZinaida M. Zhigula0https://orcid.org/0000-0002-8762-9914Albina A. Zhilina1https://orcid.org/0000-0002-4405-2975Natalia V. Lareva2https://orcid.org/0000-0001-9498-9216Chita State Medical AcademyChita State Medical AcademyChita State Medical AcademyObjective: To analyze literature data and compare the common pathways of inflammation in inflammatory bowel diseases (IBD) and atherosclerosis with focus on the effects of proinflammatory cytokines on both pathologies, as well as from the perspective of potential role of gene polymorphism of proinflammatory cytokines in the pathophysiology of atherosclerosis in IBD patients. Main provisions: In IBD, a serum cytokine profile initiates and supports the chronic inflammation. The main immunological mechanisms in both IBD and atherosclerosis are mediated by hyperproduction of proinflammatory cytokines, such as tumor necrosis factor α (TNF-α), interleukins (IL) IL-1β, IL-6, IL-8, IL-12, IL-23, IL-17, and relative insufficiency of anti-inflammatory IL-4 and IL-10, with significant increase in pro-inflammatory cytokines. An association has been established between the polymorphisms of TNF-α (rs1800629), IL-8 (rs117518778, rs8057084), IL-10 (rs3024505, rs1800896), IL-12 (rs6887695, rs10045431), IL-23 (rs11209026A) candidate genes and the development of ulcerative colitis (UC). The polymorphisms of the TNF-α (rs1800629), IL-8 (rs117518778, rs8057084), IL-1β (rs16944), IL-17A (rs2275913), IL-4 (rs2243250), IL-23 (rs6682925T/C) genes are associated with a high risk of atherosclerosis. Protein tyrosine phosphatase, receptor type, C (PTPRC) was identified as the hub crosstalk gene for the comorbidity of UC and atherosclerosis. The effects of cytokine genes polymorphisms as key targets of the pathogenetically oriented IBD therapy on the development of atherosclerosis in these patients remain a poorly investigated question. Conclusion: IBD and atherosclerosis are mediated by the shared mechanisms of enhanced synthesis of proinflammatory cytokines, as well as polymorphisms of the candidate genes. Studies on the polymorphism of proinflammatory cytokines genes and small molecules in patients with UC, as well as the association of these polymorphisms with the development of atherosclerosis would open up new possibilities for prediction of cardiovascular diseases in these patients, development of preventive measures, and for repositioning of biological therapy for the prevention and treatment of atherosclerosis.https://almclinmed.ru/jour/article/viewFile/17271/1709inflammatory bowel diseasesulcerative colitiscrohn's diseaseatherosclerosischronic inflammationpro-inflammatory cytokinesgene polymorphism
spellingShingle Zinaida M. Zhigula
Albina A. Zhilina
Natalia V. Lareva
Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokines
Alʹmanah Kliničeskoj Mediciny
inflammatory bowel diseases
ulcerative colitis
crohn's disease
atherosclerosis
chronic inflammation
pro-inflammatory cytokines
gene polymorphism
title Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokines
title_full Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokines
title_fullStr Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokines
title_full_unstemmed Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokines
title_short Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokines
title_sort common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis a focus on cytokines
topic inflammatory bowel diseases
ulcerative colitis
crohn's disease
atherosclerosis
chronic inflammation
pro-inflammatory cytokines
gene polymorphism
url https://almclinmed.ru/jour/article/viewFile/17271/1709
work_keys_str_mv AT zinaidamzhigula commonpathogeneticmechanismsofinflammatoryboweldiseasesandatherosclerosisafocusoncytokines
AT albinaazhilina commonpathogeneticmechanismsofinflammatoryboweldiseasesandatherosclerosisafocusoncytokines
AT nataliavlareva commonpathogeneticmechanismsofinflammatoryboweldiseasesandatherosclerosisafocusoncytokines